According to a recent LinkedIn post from Certify, recent Centers for Medicare & Medicaid Services (CMS) reimbursement changes are altering hospital outpatient revenue flows by an estimated $290 million. The post highlights that drug administration payments at off-campus hospital departments have reportedly been reduced to 40% of the standard rate, while 285 procedures have shifted into ambulatory and ambulatory surgery center (ASC) eligibility.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests this policy change could compress margins for hospital outpatient departments and push providers to reassess cost structures and care settings. At the same time, ambulatory and ASC operators may face operational strain, as higher patient volumes and more complex intake and scheduling introduce friction and coordination challenges.
According to the post, these dynamics may increase the strategic importance of workflow, scheduling, and communication tools that can handle higher throughput without sacrificing continuity of care. Certify’s LinkedIn content positions the company’s CERTIFY Health platform as aimed at integrating intake, scheduling, and communication, which could be relevant to investors assessing its role in supporting providers’ adaptation to shifting CMS reimbursement and site-of-care trends.

